Aging Vessels: A Breakthrough in Vascular Regeneration
In Aging Cell, researchers have linked macrophage senescence to the failure of new blood vessel formation, finding a key target that might make it easier to treat […]
In Aging Cell, researchers have linked macrophage senescence to the failure of new blood vessel formation, finding a key target that might make it easier to treat […]
Junevity founder explains how developments in siRNA therapeutics are enabling new ways to return cells to healthier states. Earlier this … Continue reading "Does gene silencing technology hold the key...
Company demonstrates treatment with intravenous fibroblasts can facilitate remyelination in the brains of mice. Regenerative medicine biotech FibroBiologics is claiming … Continue reading "FibroBiologics hails brain tissue repair breakthrough" The...
Using a mouse model, researchers from UCSF have found that the genes that become activated on the silent X chromosome might explain some sex-dependent differences in cognitive abilities during aging...
Elevant’s best-selling biohacking product provides rapid NAD+ support, but its fast absorption enhances its effectiveness. Nicotinamide adenine dinucleotide (NAD+) is … Continue reading "Optima: The fast-absorbing NMN supplement gaining attention"...
Company gears up for pivotal trials of AI-developed IPF drug candidate following encouraging Phase 2 data. AI-driven drug discovery powerhouse … Continue reading "Insilico seals unicorn status after landing $110m...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
Progress in spinal cord injury lays the foundation for regenerative therapies that ‘target aging and chronic disease at a cellular … Continue reading "Cellino’s regenerative medicine tie-up with Matricelf is...
Regenerative medicine startup aims to regenerate damaged tissues, modulate chronic inflammation and extend functional healthspan. Longevity biotech ReParris has launched … Continue reading "ReParris emerges to redefine aging as a...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
CTA Content